Seropositivity to Nucleoprotein to detect SARS-CoV-2 infections: a tool to detect breakthrough infections after COVID-19 vaccination

Lotus L. van den Hoogen, Gaby Smits, Cheyenne C.E. van Hagen, Denise Wong, Eric R.A. Vos, Michiel van Boven, Hester E. de Melker, Jeffrey van Vliet, Marjan Kuijer, Linde Woudstra, Alienke J. Wijmenga-Monsuur, Corine H. GeurtsvanKessel, Susanne P. Stoof, Daphne Reukers, Lisa A. Wijsman, Adam Meijer, Chantal B.E.M. Reusken, Nynke Y. Rots, Fiona R.M. van der Klis, Robert S. van Binnendijk, Gerco den Hartog
doi: https://doi.org/10.1101/2021.10.05.21264555

Data Availability

Data are available from the authors upon reasonable request.

Back to top
Posted October 07, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Seropositivity to Nucleoprotein to detect SARS-CoV-2 infections: a tool to detect breakthrough infections after COVID-19 vaccination
Lotus L. van den Hoogen, Gaby Smits, Cheyenne C.E. van Hagen, Denise Wong, Eric R.A. Vos, Michiel van Boven, Hester E. de Melker, Jeffrey van Vliet, Marjan Kuijer, Linde Woudstra, Alienke J. Wijmenga-Monsuur, Corine H. GeurtsvanKessel, Susanne P. Stoof, Daphne Reukers, Lisa A. Wijsman, Adam Meijer, Chantal B.E.M. Reusken, Nynke Y. Rots, Fiona R.M. van der Klis, Robert S. van Binnendijk, Gerco den Hartog
medRxiv 2021.10.05.21264555; doi: https://doi.org/10.1101/2021.10.05.21264555
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area